233 related articles for article (PubMed ID: 31263571)
21. Germline pathogenic variants identified in women with ovarian tumors.
Carter NJ; Marshall ML; Susswein LR; Zorn KK; Hiraki S; Arvai KJ; Torene RI; McGill AK; Yackowski L; Murphy PD; Xu Z; Solomon BD; Klein RT; Hruska KS
Gynecol Oncol; 2018 Dec; 151(3):481-488. PubMed ID: 30322717
[TBL] [Abstract][Full Text] [Related]
22. Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.
Torrezan GT; de Almeida FGDSR; Figueiredo MCP; Barros BDF; de Paula CAA; Valieris R; de Souza JES; Ramalho RF; da Silva FCC; Ferreira EN; de Nóbrega AF; Felicio PS; Achatz MI; de Souza SJ; Palmero EI; Carraro DM
Front Genet; 2018; 9():161. PubMed ID: 29868112
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
[TBL] [Abstract][Full Text] [Related]
25. Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women.
Sepahi I; Faust U; Sturm M; Bosse K; Kehrer M; Heinrich T; Grundman-Hauser K; Bauer P; Ossowski S; Susak H; Varon R; Schröck E; Niederacher D; Auber B; Sutter C; Arnold N; Hahnen E; Dworniczak B; Wang-Gorke S; Gehrig A; Weber BHF; Engel C; Lemke JR; Hartkopf A; Nguyen HP; Riess O; Schroeder C
BMC Cancer; 2019 Aug; 19(1):787. PubMed ID: 31395037
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
[TBL] [Abstract][Full Text] [Related]
27. Whole-Exome Sequencing of Germline Variants in Non-
Liu Y; Helgadottir HT; Kharaziha P; Choi J; López-Giráldez F; Mane SM; Höiom V; Juhlin CC; Larsson C; Bajalica-Lagercrantz S
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625741
[TBL] [Abstract][Full Text] [Related]
28. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.
Blanco A; Gutiérrez-Enríquez S; Santamariña M; Montalban G; Bonache S; Balmaña J; Carracedo A; Diez O; Vega A
Breast Cancer Res Treat; 2014 Aug; 147(1):133-43. PubMed ID: 25086635
[TBL] [Abstract][Full Text] [Related]
29. Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.
Zhao Q; Yang J; Li L; Cao D; Yu M; Shen K;
J Gynecol Oncol; 2017 Jul; 28(4):e39. PubMed ID: 28541631
[TBL] [Abstract][Full Text] [Related]
30. Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome.
Fortuno C; James PA; Spurdle AB
Hum Mutat; 2018 Dec; 39(12):1764-1773. PubMed ID: 30240537
[TBL] [Abstract][Full Text] [Related]
31. Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants.
Freire MV; Martin M; Thissen R; Van Marcke C; Segers K; Sépulchre E; Leroi N; Lété C; Fasquelle C; Radermacher J; Gokburun Y; Collignon J; Sacré A; Josse C; Palmeira L; Bours V
Front Oncol; 2022; 12():835581. PubMed ID: 35280729
[TBL] [Abstract][Full Text] [Related]
32. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
[TBL] [Abstract][Full Text] [Related]
33.
Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
[TBL] [Abstract][Full Text] [Related]
34. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Mouren A; Chansavang A; Hamzaoui N; Srikaran A; Laurent-Puig P; Marisa L; De Percin S; Lupo A; Larousserie F; Blons H; L'Haridon A; Burnichon N; Pasmant E; Tlemsani C
Fam Cancer; 2024 May; ():. PubMed ID: 38763984
[TBL] [Abstract][Full Text] [Related]
35. Germline mutations in cancer-predisposition genes in patients with biliary tract cancer.
Terashima T; Umemoto K; Takahashi H; Hosoi H; Takai E; Kondo S; Sakamoto Y; Mitsunaga S; Ohno I; Hashimoto Y; Sasaki M; Ikeda M; Shimada K; Kaneko S; Yachida S; Sugano K; Okusaka T; Morizane C
Oncotarget; 2019 Oct; 10(57):5949-5957. PubMed ID: 31666926
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of pathogenic germline variants in adult-type diffuse glioma.
McDonald MF; Prather LL; Helfer CR; Ludmir EB; Echeverria AE; Yust-Katz S; Patel AJ; Deneen B; Rao G; Jalali A; Dhar SU; Amos CI; Mandel JJ
Neurooncol Pract; 2023 Oct; 10(5):482-490. PubMed ID: 37720399
[TBL] [Abstract][Full Text] [Related]
37. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation.
Brianese RC; Nakamura KDM; Almeida FGDSR; Ramalho RF; Barros BDF; Ferreira ENE; Formiga MNDC; de Andrade VP; de Lima VCC; Carraro DM
Breast Cancer Res Treat; 2018 Feb; 167(3):803-814. PubMed ID: 29116469
[TBL] [Abstract][Full Text] [Related]
39. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
[TBL] [Abstract][Full Text] [Related]
40. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.
Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L
Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
